Novo Seeks RNA Approach to Obesity, Diabetes With $550M Replicate Deal
Novo Nordisk has brought on other cardiometabolic collaborators this year, including United Laboratories International and Deep Apple Therapeutics.
Novo Seeks RNA Approach to Obesity, Diabetes With $550M Replicate Deal Read More »
